Sierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737

Press/Media: Press / Media

PeriodNov 29 2018 → Nov 30 2018

Media coverage

19

Media coverage

  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletCanadian Life Sciences Database
    CountrySwitzerland
    Date11/30/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletBiotechgate
    CountrySwitzerland
    Date11/30/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletBioSpace
    CountryUnited States
    Date11/30/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletPipelineReview
    CountrySpain
    Date11/30/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletCanada NewsWire
    CountryCanada
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletPR Newswire
    CountryUnited States
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletCanada NewsWire
    CountryCanada
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletPR Newswire
    CountryUnited States
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletCanada NewsWire
    CountryCanada
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletPR Newswire
    CountryUnited States
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletNasdaq
    CountryUnited States
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletIndia Pharma News
    CountryIndia
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletTickerTech.com
    CountryUnited States
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletStockwatch
    CountryCanada
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletPharmiWeb
    CountryUnited Kingdom
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletFinanzen.ch
    CountrySwitzerland
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletMarkets Business Insider
    CountryUnited States
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletSpoke.com
    CountryUnited States
    Date11/29/18
    PersonsJing Wang
  • TitleSierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
    Media name/outletCentral Charts
    CountryFrance
    Date11/29/18
    PersonsJing Wang